Sharon Hemond Hrynkow is Chief Scientific Officer at Cyclo Therapeutics, Inc. (CTDH). They have made 5 open-market trades across 3 companies since 2018, most recently 2022-12-20.
CIK 0001745677
5 open-market purchases totalling $29K since 2018, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| FORD | BUY | 2022-12-20 | 2022-12-21 | $1.14 | $11K | -5.9% | +17.2% | -8.2% |
| CYTH | BUY | 2021-12-02 | 2021-12-02 | $4.98 | $5K | -20.0% | -19.0% | -33.1% |
| CYTH | BUY | 2021-03-29 | 2021-03-30 | $7.46 | $7K | -17.5% | -1.1% | +28.5% |
| CTDH | BUY | 2019-08-01 | 2019-08-02 | $0.25 | $2K | N/A | N/A | N/A |
| CTDH | BUY | 2019-07-31 | 2019-07-31 | $0.24 | $2K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.